Influence of CYP3A5 polymorphism on tacrolimus maintenance doses and serum levels after renal transplantation: Age dependency and pharmacological interaction with steroids

Pharmacogenetics of Immunosuppressant Polymorphism of CYP3A5 in Renal Transplant Recipients

(2010) J. Larriba et al.   TRANSPLANTATION PROCEEDINGS

Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients

(2009) W Zhao et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients

(2009) Shigeru Satoh et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Tacrolimus Concentrations in Relation to CYP3A and ABCB1 Polymorphisms Among Solid Organ Transplant Recipients in Korea

(2009) Kyung Ran Jun et al.   TRANSPLANTATION

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

(2008) Dennis A. Hesselink et al.   Pharmacogenetics and Genomics

Maturation of Dose-Corrected Tacrolimus Predose Trough Levels in Pediatric Kidney Allograft Recipients

(2008) Maarten Naesens et al.   TRANSPLANTATION